Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:LABU NYSEARCA:PJP NYSEARCA:RSPH NYSEARCA:XPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABUDirexion Daily S&P Biotech Bull 3x Shares$242.00-1.7%$230.37$58.35▼$333.00$561.44M2.39603,144 shs330,469 shsPJPInvesco Pharmaceuticals ETF$122.74+1.8%$114.84$80.63▼$123.23$446.77M0.4536,749 shs99,610 shsRSPHInvesco S&P 500 Equal Weight Health Care ETF$35.19+3.1%$32.63$27.33▼$35.21$773.83M0.78114,471 shs48,065 shsXPHSPDR S&P Pharmaceuticals ETF$69.00+0.7%$63.17$40.80▼$70.15$479.55M0.5886,445 shs66,880 shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABUDirexion Daily S&P Biotech Bull 3x Shares+0.27%-1.14%-10.82%+39.06%+275.87%PJPInvesco Pharmaceuticals ETF+0.19%+2.28%+1.63%+15.98%+42.64%RSPHInvesco S&P 500 Equal Weight Health Care ETF+0.98%+1.43%+1.91%+12.45%+16.52%XPHSPDR S&P Pharmaceuticals ETF+0.87%+2.21%+3.97%+19.51%+58.36%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABUDirexion Daily S&P Biotech Bull 3x Shares$242.00-1.7%$230.37$58.35▼$333.00$561.44M2.39603,144 shs330,469 shsPJPInvesco Pharmaceuticals ETF$122.74+1.8%$114.84$80.63▼$123.23$446.77M0.4536,749 shs99,610 shsRSPHInvesco S&P 500 Equal Weight Health Care ETF$35.19+3.1%$32.63$27.33▼$35.21$773.83M0.78114,471 shs48,065 shsXPHSPDR S&P Pharmaceuticals ETF$69.00+0.7%$63.17$40.80▼$70.15$479.55M0.5886,445 shs66,880 shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABUDirexion Daily S&P Biotech Bull 3x Shares+0.27%-1.14%-10.82%+39.06%+275.87%PJPInvesco Pharmaceuticals ETF+0.19%+2.28%+1.63%+15.98%+42.64%RSPHInvesco S&P 500 Equal Weight Health Care ETF+0.98%+1.43%+1.91%+12.45%+16.52%XPHSPDR S&P Pharmaceuticals ETF+0.87%+2.21%+3.97%+19.51%+58.36%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABUDirexion Daily S&P Biotech Bull 3x Shares 2.68Moderate Buy$242.00N/APJPInvesco Pharmaceuticals ETF 2.67Moderate Buy$122.74N/ARSPHInvesco S&P 500 Equal Weight Health Care ETF 2.53Moderate Buy$35.19N/AXPHSPDR S&P Pharmaceuticals ETF 2.71Moderate Buy$69.00N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABUDirexion Daily S&P Biotech Bull 3x SharesN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/ARSPHInvesco S&P 500 Equal Weight Health Care ETFN/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABUDirexion Daily S&P Biotech Bull 3x SharesN/AN/AN/AN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/A15.59N/AN/AN/AN/AN/AN/ARSPHInvesco S&P 500 Equal Weight Health Care ETFN/AN/A21.06N/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/A14.28N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLABUDirexion Daily S&P Biotech Bull 3x Shares$1.010.42%N/AN/AN/APJPInvesco Pharmaceuticals ETF$1.060.86%N/AN/AN/ARSPHInvesco S&P 500 Equal Weight Health Care ETF$0.230.65%N/AN/AN/AXPHSPDR S&P Pharmaceuticals ETF$0.330.48%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABUDirexion Daily S&P Biotech Bull 3x SharesN/APJPInvesco Pharmaceuticals ETFN/ARSPHInvesco S&P 500 Equal Weight Health Care ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/AInsider OwnershipCompanyInsider OwnershipLABUDirexion Daily S&P Biotech Bull 3x SharesN/APJPInvesco Pharmaceuticals ETFN/ARSPHInvesco S&P 500 Equal Weight Health Care ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABUDirexion Daily S&P Biotech Bull 3x SharesN/A2.32 millionN/ANot OptionablePJPInvesco Pharmaceuticals ETFN/A3.64 millionN/ANot OptionableRSPHInvesco S&P 500 Equal Weight Health Care ETFN/A21.99 millionN/ANot OptionableXPHSPDR S&P Pharmaceuticals ETFN/A6.95 millionN/ANot OptionableLABU, XPH, PJP, and RSPH HeadlinesRecent News About These CompaniesPharmaceuticals still a defensive play amid AI and geopolitical anxieties – analystJuly 21, 2026 | seekingalpha.comHealthcare Rules State Street's Top 5 ETFs in Past MonthJuly 17, 2026 | etftrends.comEWhich Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?July 8, 2026 | aol.comASPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0590June 22, 2026 | msn.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?June 5, 2026 | zacks.comUS FDA to review AI-based tool to predict drug-related liver damageJune 3, 2026 | reuters.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?June 3, 2026 | zacks.comDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?May 19, 2026 | 247wallst.comTrump to announce discount drug pricing expansion, White House official saysMay 18, 2026 | reuters.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?April 3, 2026 | zacks.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?March 30, 2026 | zacks.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0610March 23, 2026 | msn.comUS and China clash over fentanyl and tariffs at global drugs meetingMarch 9, 2026 | reuters.comThese 5 Undervalued ETFs Could Be Bargains Right NowFebruary 26, 2026 | 247wallst.comXPH’s 29% Run Looks Tempting, But The 5y Chart Is A WarningFebruary 18, 2026 | 247wallst.comXPH's 29% Run Looks Tempting, But The 5y Chart Is A WarningFebruary 18, 2026 | 247wallst.comIs State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?January 29, 2026 | zacks.comShould You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?January 28, 2026 | zacks.comXPH: Healthcare Dashboard For JanuaryJanuary 16, 2026 | seekingalpha.comState Street® SPDR® S&P® Pharmaceuticals ETFJanuary 11, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLABU, XPH, PJP, and RSPH Company DescriptionsDirexion Daily S&P Biotech Bull 3x Shares NYSEARCA:LABU$242.00 -4.27 (-1.73%) As of 04:10 PM EasternThe Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Invesco Pharmaceuticals ETF NYSEARCA:PJP$122.74 +2.14 (+1.77%) As of 04:10 PM EasternPowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.Invesco S&P 500 Equal Weight Health Care ETF NYSEARCA:RSPH$35.19 +1.06 (+3.11%) As of 04:10 PM EasternThe Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of US health care companies taken from the S&P 500 Index. RSPH was launched on Nov 1, 2006 and is managed by Invesco.SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH$69.00 +0.46 (+0.67%) As of 04:10 PM EasternSPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas These 3 Stocks Have Soared in 2026—Can They Keep Climbing? Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction Amkor Sells Off After Earnings—Why Weak Guidance Isn't the Real Story Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus Western Digital’s Earnings Will Test Whether Its AI Rally Has More Room 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys? Is the Market Mispricing ServiceNow's AI Future? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
